Connect your AI

Chemed CHE Price / earnings

Price / earnings at other companies

HCA HealthcareHCA

15.6×+0.9×

Other financials

Income statement

Revenue$657.5M+1.6%

Gross profit$215.8M-0.3%

Operating income$84.6M-10.7%

Net income$66.3M-7.6%

EPS (diluted)$4.84-0.4%

Balance sheet

Cash & equivalents$16.9M-90.3%

Total debt$236.9M+63.3%

Total equity$848.0M-28.2%

Total assets$1.5B-11.0%

Cash flow

Operating cash flow$88.2M+169%

CapEx$17.1M+28.9%

Free cash flow$71.1M+265%

Valuation

Market cap$5.79B-42.3%

Enterprise value$6.01B-39.6%

P/S2.3×-1.8×

Profitability

Gross margin32.4%-2.4pp

Operating margin12.9%-2.7pp

Net margin10.2%-2.2pp

FCF margin14.8%+2.2pp

Returns & leverage

Return on equity25.6%-0.5pp

Debt / equity0.3×+0.2×

Current ratio0.9×-0.9×

Where this comes from

Calculated from Chemed’s reported figures.

market cap/net income=20×

Based on the most recent quarter.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Chemed's price / earnings?: Chemed (CHE) reported price / earnings of 20× in Q1 2026.
How has Chemed's price / earnings changed year-over-year?: Chemed's price / earnings decreased by 31.4% year-over-year, from 29.2× to 20×.
What is the long-term trend for Chemed's price / earnings?: Over 5 years (2020 to 2025), Chemed's price / earnings has grown at a -3.1% compound annual growth rate (CAGR), from 26.7× to 22.8×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.